161.00
161.00
Inclusive of all taxes
You Save: 0. Discount 0%
Product is not available
DOXOSIGN 400 Tablet is a high-quality respiratory medication formulated with Doxofylline, a methylxanthine derivative used for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD). It acts as a bronchodilator, helping to relax smooth muscles in the airways, improving airflow and easing breathing difficulties. Manufactured under strict WHO-GMP standards by BluepillExpress, DOXOSIGN 400 is designed for maximum efficacy with minimal side effects and is ideal for domestic distribution and global export.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
DOXOSIGN 400 Tablet, containing Doxofylline 400 mg, is a reliable oral bronchodilator medication used in the management of bronchial asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). Doxofylline is a methylxanthine class agent similar to theophylline but with better tolerability and fewer cardiovascular and central nervous system side effects. It functions by relaxing bronchial smooth muscle, thereby improving airflow and reducing symptoms like wheezing, shortness of breath, and chest tightness.
DOXOSIGN 400 is produced by BluepillExpress, a leading pharmaceutical manufacturer and exporter in India known for high-precision formulations and regulatory compliance. The product is suitable for bulk export, third-party manufacturing, and custom branding, especially for markets in Asia, Africa, Latin America, and CIS regions.
The medication is typically prescribed as part of maintenance therapy in patients with persistent or severe forms of obstructive airway diseases. It offers a sustained bronchodilatory effect, helping reduce the frequency and severity of respiratory episodes, enhancing lung function, and improving quality of life.
The formulation of DOXOSIGN 400 ensures rapid absorption and controlled action, supporting efficient symptom relief with minimal fluctuation in plasma drug levels. Unlike theophylline, it is less likely to interact with food and other drugs, making it safer and more convenient for long-term use.
Product Highlights
Active Ingredient: Doxofylline 400 mg
Indications: Bronchial asthma, COPD, chronic bronchitis
Mechanism of Action: Relaxes bronchial smooth muscles via phosphodiesterase inhibition
Form: Film-coated oral tablet
Frequency: As directed by physician (commonly twice daily)
Pharmacological Profile
Drug Class: Methylxanthine derivative
Bioavailability: High oral absorption
Onset of Action: Within 30–60 minutes
Half-life: 6–7 hours
Metabolism: Hepatic
Elimination: Renal
Clinical Benefits
Provides long-lasting bronchodilation
Fewer side effects compared to theophylline
Minimal impact on cardiac and CNS functions
Safe for long-term respiratory care
Can be co-administered with corticosteroids or beta-agonists
